HCA Healthcare, Inc. (HCA) Stock Analysis
Is HCA a good investment?
HCA Healthcare, Inc. (HCA) has a Plutrex AI rating of 72.5/100 as of May 26, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Exceptional free cash flow generation of $5.82B provides strong cash conversion and financial flexibility. Main concern: Significant growth underperformance with 10.1% forward EPS growth vs 24.8% industry average (-59.4%).
Investment Summary
HCA presents a mixed investment opportunity with strong operational efficiency (16.3% operating margin vs 11.1% industry average) and exceptional cash generation ($5.82B free cash flow), but trades at a growth premium (PEG 1.52 vs 1.33 industry) despite significantly slower growth (10.1% forward EPS growth vs 24.8% industry). The 50.8% PE discount (17.44 vs 35.46) creates value opportunity, while positive healthcare sector momentum from demographic trends and employment growth supports the thesis.
Key Strengths
- Exceptional free cash flow generation of $5.82B provides strong cash conversion and financial flexibility
- Superior operational efficiency with 16.3% operating margin vs 11.1% industry average (+46.8%)
- Attractive valuation discount with PE of 17.44 vs industry 35.46 (-50.8%) despite quality operations
Key Concerns
- Significant growth underperformance with 10.1% forward EPS growth vs 24.8% industry average (-59.4%)
- High cost structure evidenced by 15.83% gross margin vs 24.61% industry average (-35.6%)
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
HCA shows mixed fundamentals with operational excellence but growth concerns. PE ratio of 17.44 represents 50.8% discount to industry average of 35.46, indicating value opportunity. However, PEG ratio of 1.52 vs industry 1.33 shows growth premium. Profitability is strong with operating margin of 16.3% vs industry 11.1% (+46.8%) and net margin of 8.97% vs 5.69% (+57.6%), but gross margin of 15.83% lags industry 24.61% (-35.6%). Critical weakness: forward EPS growth of 10.1% vs industry 24.8% (-59.4%). Financial health is solid with $5.82B free cash flow and $1.14B cash, though missing debt-to-equity data limits assessment.
News Sentiment
HCA Healthcare is riding a wave of positive momentum in the healthcare sector, positioning itself to benefit from powerful demographic and employment trends reshaping America's medical landscape. Recent jobs data revealed robust healthcare employment growth, signaling strong sector expansion that could drive increased patient volumes and revenue growth for hospital operators like HCA. The company recently earned recognition as one of the '2026 World's Most Ethical Companies' by Ethisphere, enhancing its reputation among stakeholders and potentially attracting ESG-focused investors. Wall Street analysts are increasingly bullish on healthcare stocks, with some predicting potential rallies of 60% or more for select companies in the sector. The underlying fundamentals supporting this optimism are compelling: demographic shifts will result in retirement-age adults outnumbering minors within the decade, creating sustained demand for healthcare services. This demographic tsunami, combined with steady employment growth in the sector, suggests HCA is well-positioned to capitalize on long-term structural tailwinds. For investors seeking exposure to America's aging population and healthcare infrastructure needs, HCA represents a quality operator with strong operational efficiency trading at a significant discount to industry peers.
Risk Assessment
Primary risk is sustained growth underperformance vs industry peers, which could limit multiple expansion. High cost structure (low gross margins) creates vulnerability to pricing pressure. Missing debt data prevents full leverage assessment. Mitigation: Strong free cash flow provides downside protection, demographic tailwinds support long-term demand, and operational efficiency demonstrates management capability.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is HCA a halal stock?
No, HCA Healthcare, Inc. (HCA) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for HCA?
HCA Healthcare, Inc. (HCA) has a Plutrex AI rating of 72.5/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is HCA a good investment?
According to Plutrex AI, HCA has a Buy rating (72.5/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in HCA?
US stocks like HCA can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in HCA?
Plutrex AI identifies the main risks for HCA by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.